Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and Pharmacodynamic Study of Temsirolimus in Renal Cell Carcinoma Patients
2011-001113-14Phase 4Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of temsirolimus in renal cell carcinoma (RCC), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Pharmacokinetic profile of temsirolimus and sirolimus. Started Nov 2011; status: active.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2011-001113-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001113-14.